Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhPTH 1-84 for acute Charcot foot fracture healing
2009-016873-13Phase 4Completed
- Sponsor
- King's College Hospital
- Start
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Charcot neuroarthropathy (CN) comparing Preotact plus standard treatment with Placebo plus standard treatment (2 arms). Primary endpoint: Clinical resolution at 6 and 12 months. Started Mar 2010; status: completed.
02
Drugs
parathyroid hormone 1-84
03
Conditions
Charcot neuroarthropathy (CN)
Beyond the preview
Go deeper on 2009-016873-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016873-13.